Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biosims Technologies

Biosims Technologies
2010 FOUNDED
OOB STATUS
11-20 EMPLOYEES
Liquidation LATEST DEAL TYPE
Description

Developer and manufacturer of high-performance analytical tools for life science industries. The company's Dynaxi detection platform, its software and kits allows extremely low amounts of targets in a sample to be monitored, at a level never reached so far on a chip device.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
  • Seine biopolis II
  • 75, Route de Lyons la forĂȘt
  • 76000 Rouen
  • France

+33 09 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Biosims Technologies’s full profile, request a free trial.

Biosims Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 27-Dec-2016 00.000 Completed Bankruptcy: Liquidation
4. Early Stage VC 22-May-2015 00.000 00.000 Completed Startup
3. Early Stage VC 12-Dec-2013 Completed Startup
2. Debt - General Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Biosims Technologies Executive Team (5)

Name Title Board
Seat
Contact
Info
Christine Heuclin Chief Executive Officer & Co-Founder
Adrian Horgan Ph.D Chief Technology Officer
Jean Belouard Sales Manager & European Sales Director
Guillaume Legent Ph.D Co-Founder & Senior Scientist

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »